JESSICA WOOTEN: Open Payments
NPI 1649755497 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 39 payments from 8 companies in 2025. Trend: 2023 $285 · 2024 $307 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $330 |
| Astellas Pharma US Inc | 6 | $190 |
| Axsome Therapeutics, Inc. | 9 | $157 |
| ABBVIE INC. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Braeburn Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: CAPLYTA, Veozah, Auvelity, QULIPTA, REXULTI, VRAYLAR, BRIXADI, XYOSTED.
Industry payments across LA — which companies pay providers there.
